On Monday, the U.S. Food and Drug Administration approved the Pfizer-BioNTech COVID-19 vaccine. The  vaccine will now be known as Comirnaty, for the prevention of COVID-19 disease in individuals 16 years of age and older. it will still continue to be made available for Emergency Use Authorization (EUA) for individuals 12-15 years of age and for the administration of a third dose in certain immunocompromised individuals.

Read Full Press Release at FDA